...Mapi-Pharma Ltd., Ness Ziona, Israel Mylan N.V. (NASDAQ:MYL), Canonsburg, Pa. Business: Neurology Alicia Parker Glatiramer acetate Depot (ga depot) Mapi-Pharma Ltd. Mylan...

...TPEx-E:6521) (D) 3/9/16 TBD Mkt (tools & services) Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Mapi-Pharma Ltd....

...TBD Ph II AnaptysBio Inc. 9/9/15 TBD Preclin Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Mapi-Pharma Ltd....

...Inc. (NYSE) 8/26/15 Up to $1B Mkt (device) Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Mapi-Pharma Ltd....

...N.V. (NYSE) 6/8/15 Up to $100M Mkt (services) Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Mapi-Pharma Ltd....

...U.A. (NYSE) 6/8/15 Up to $100M Mkt (services) Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Mapi-Pharma Ltd....

...million Shares: 3.1 million Price: $15-$17 Underwriters: JMP Securities; Maxim Group; FBR Overallotment: 468,750 Note: Mapi-Pharma...
...In May 2014, Mapi-Pharma proposed to sell 2.7 million shares at $13-$15. In March 2014, Mapi-Pharma...

...Mkt (services) Anterios Inc. 3/31/15 $50.7M Ph II Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Mapi-Pharma Ltd....

...To be raised: TBD Shares: TBD Price: TBD Underwriters: JMP Securities; Maxim Group; FBR Note: Mapi-Pharma...
...raised. The company also removed MLV as an underwriter and added FBR. In May 2014, Mapi-Pharma...
...company proposed to sell 2.9 million shares at the same price range. In March 2014, Mapi-Pharma...

...Ph II Exagen Diagnostics Inc. 9/19/14 TBD Mkt (diagnostic) Silenseed Ltd. 6/13/14 TBD Ph I/II Mapi-Pharma Ltd....